Robert Redfield's most recent trade in Traws Pharma Inc. was a trade of 97,500 Common Stock done . Disclosure was reported to the exchange on April 1, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Traws Pharma Inc. | Robert Redfield | Acting Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 97,500 | 97,500 (0%) | 0% | - | Common Stock |